跳至主要内容
临床试验/IRCT20211221053477N1
IRCT20211221053477N1已完成3 期

The Effect of Colchicine in prevention of Pericardial Effusion after CABG, randomized clinical trial

Mazandaran University of Medical Sciences0 个研究点目标入组 260 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 80 years(—)
性别
All

入选标准

  • All patients referred to Fatemeh Zahra Heart Hospital with coronary artery disease who are candidates for coronary artery bypass graft surgery

排除标准

  • Patients over 80 years old
  • Presence of pericardial effusion in preoperative trans-thoracic echo
  • Existence of pleural effusion in CXR standing before surgery
  • Chronic lung, liver disease (known case of liver disease or LFT more than 3 times normal) and kidney disease (known case of kidney disease or Cr> 2.5)
  • Other heart surgeries at the same time as coronary artery bypass grafting
  • Patients who was allergic reaction to colchicine or given colchicine in any way are contraindicated
  • pregnant patients
  • Patients receiving colchicine before starting of study

研究者

相似试验